Antibody-guided lymphangiography in the staging of cervical cancer Sir-We read with interest the report on antibody guided lymphangiography in the staging of cervical cancer (Epenetos, 1985) .
The author reports the occurrence of non specific isotope uptake by pelvic lymph nodes in patients presented to be free of nodal metastasis (as judged by concomitant X-ray lymphangiography). Non specific antibody binding through the Fc portion of the immunoglobulin was postulated as the cause of this phenomenon.
We would suggest, however, that the effect may be partly explained by the presence of X-ray contrast medium in the lymphatics. We have performed similar antibody studies using a polyclonal anti CEA antibody linked to iodine131. Figure 1 illustrates the gamma camera image of the anterior pelvis 24 h following injection of labelled antibody in a patient with Stage Ib carcinoma of the cervix. There is a difference between the two sides of the pelvis on this scan with small discrete areas of uptake on the right but broader more diffuse areas of uptake on the left. Subsequent pelvic lymphadenectomy revealed no evidence of lymph node metastases. Standard bipedal X-ray lymphangiography had been performed in this case but technical problems had prevented an adequate infusion of Lipiodol into the lymphatics of the right leg and this fact may explain the asymmetry seen on the antibody guided scan. This is compatible with the known occurrence of lymph node enlargement and lymphatic stasis following lymphangiography with lipid soluble contrast medium (Spitalier et al., 1967; Wallace et al., 1979 
Dr Epenetos replies:
Sir-Thank you for bringing to our attention the letter of Saunders et al. in which it is stated that non-specific antibody binding in the pelvic lymph nodes may be partly explained by the presence of X-ray contrast medium in the lymphatics. Certainly their studies of using a polyclonal anti CEA antibody linked to iodine-131 concurrently with bipedal X-ray lymphangiography demonstrate that lipid-soluble contrast medium can interfere with antibody localisation as shown by their illustrated example. We agree therefore with them that X-ray contrast medium can be a further factor in nonspecific antibody capture by lymphatics. Since our last report on antibody guided lymphangiography (Epenetos, 1985) we have performed further lymphangiography but on this occasion administering radiolabelled antibody subcutaneously without injection of contrast. We have seen again non-specific antibody capture by lymphatics but our data so far would indicate that this capture is less than when the antibody was injected during lymphangiography, pointing again to the fact that X-ray contrast medium interferes with radioimmunolocalisation.
We also noted that the use of indium-labelled monoclonal antibodies given subcutaneously causes more marked imaging of local lymphatics as compared to iodinated antibody. This is probably due to the different kinetics of the various radiolabels after antibody breakdown. We still believe that the best way to sort out specific and non-specific binding is to perform immunolymphangiography using a specific antibody followed by a non-specific antibody. Yours etc., A.A. Epenetos Royal Postgraduate Medical School, Hammersmith Hospital, London W12 OHS
